Oxford Lane Capital Corp. Preferred Stock Shares 6.00% Series 2029 (OXLCO)

FairStock Score: 48/100 — MIXED

Key Financials

Current Price$23.55
Market Cap$437M
P/E Ratio27.07
ROE-39.17%
Dividend Yield6.37%
SectorFinancial Services

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

Looking at Oxford Lane Capital Corp. 6.00% Series 2029 preferred, I see a closed-end fund managed by Oxford Lane Management that invests mostly through securitization vehicles holding below-investment-grade senior secured loans. That is a credit-sensitive, spread-driven business, and I see no durable competitive moat in buying CLO tranches; results depend on credit selection, leverage, and market spreads. The provided figures are sobering. At the 2026-10-13 close of $23.55, the dividend yield is 6.37% and beta is 0.64, but FairStock calculations show a P/E of 27.07, P/B of 2.23, ROE of -39.17%, ROCE of 8.98%, and debt-to-equity of 0.75. FairStock's Graham Number is $14.38, leaving a margin of safety of -63.77%, which means the price is far above that conservative value. The Piotroski F-Score is 0/9 and the Altman Z-Score is -0.95, both poor financial-health signals. The 52-week range is narrow at $23.07 to $24.98, so the market is not pricing obvious distress, yet the underlying metrics suggest fragility. FairStock Score is 48/100, and the Lynch category is none because there are zero years of filed results over the three needed, so I cannot assess a multi-year record. Revenue growth and profit growth are not available. A preferred claim ranks ahead of common equity but behind debt, and the underlying loans are below investment grade. Without evidence of sustained dividend coverage and credit stability, this looks like speculative income, not a Graham-style bargain.

In plain English: Oxford Lane Capital Corp. 6.00% Series 2029 preferred stock is tied to a closed-end fund that invests mainly in securitized bundles of loans made to riskier companies. The figures show a weak business: it has been losing money on its equity, has very poor financial-health scores, and no filed growth record to judge. At $23.55, the price looks expensive compared with the value suggested by its earnings and accounting value.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer